Charles A Cooper

Title: Innovations by Charles A. Cooper

Introduction

Charles A. Cooper is an accomplished inventor based in Irvine, CA. He has made significant contributions to the field of ophthalmology through his innovative methods. His work primarily focuses on treating vascularization of the eye, which can result from various medical conditions.

Latest Patents

Charles A. Cooper holds a patent for a method of treating vascularization of the eye with Flurbiprofen. This method addresses issues arising from traumatic injuries, surgeries such as corneal transplants, or the onset of diabetic retinopathy. The treatment involves topically applying Flurbiprofen or a pharmaceutically acceptable salt thereof to the affected eye. This patent showcases his dedication to improving eye health and patient outcomes.

Career Highlights

Cooper is currently employed at Allergan Pharmaceuticals, a leading company in the field of eye care and pharmaceuticals. His role at Allergan allows him to work on cutting-edge treatments that can significantly impact patients' lives. With a focus on innovation, he continues to push the boundaries of what is possible in ophthalmic treatments.

Collaborations

One of his notable collaborators is Michael V. Bergamini. Together, they have worked on various projects aimed at enhancing treatment options for eye-related conditions. Their partnership exemplifies the importance of collaboration in the field of medical innovation.

Conclusion

Charles A. Cooper's contributions to ophthalmology through his patent and work at Allergan Pharmaceuticals highlight his commitment to advancing medical treatments. His innovative approach to treating vascularization of the eye demonstrates the potential for significant improvements in patient care.